• Table of Contents

  • New Partnership Between the Mauritanian Drug Control Laboratory and the Algerian Accreditation Body
  • Strengthening Regional Cooperation in Pharmaceutical Quality Control
  • Key Objectives of the Partnership
  • Implications for Public Health and Regional Integration
  • Conclusion: A Step Forward for Pharmaceutical Excellence

New Partnership Between the Mauritanian Drug Control Laboratory and the Algerian Accreditation Body

Strengthening Regional Cooperation in Pharmaceutical Quality Control

In a significant step towards enhancing pharmaceutical oversight in the Maghreb region, the Mauritanian Drug Control Laboratory (Laboratoire Mauritanien de Contrôle des Médicaments – LMCM) has entered into a strategic partnership with the Algerian Accreditation Body (Organisme Algérien d’Accréditation – ALGERAC). This collaboration aims to elevate the standards of drug quality control in Mauritania by aligning with internationally recognized accreditation protocols.

The agreement was formalized during a high-level meeting between representatives of both institutions, where they emphasized the importance of mutual cooperation in ensuring the safety and efficacy of medicines. The partnership is expected to facilitate the exchange of technical expertise, training programs, and the implementation of best practices in laboratory accreditation and pharmaceutical analysis.

Key Objectives of the Partnership

The collaboration between LMCM and ALGERAC is built on a shared vision of improving public health through rigorous drug quality assurance. The main goals of the partnership include:

• Supporting the Mauritanian laboratory in obtaining international accreditation in line with ISO/IEC 17025 standards.
• Enhancing the technical capabilities of LMCM through specialized training and capacity-building initiatives.
• Promoting the harmonization of pharmaceutical control procedures between Mauritania and Algeria.
• Facilitating the exchange of scientific knowledge and laboratory methodologies.

By achieving these objectives, both institutions aim to contribute to a more robust and reliable pharmaceutical regulatory environment in the region.

Implications for Public Health and Regional Integration

This partnership marks a milestone in regional integration efforts in the health sector. It reflects a growing recognition of the need for cross-border collaboration to address shared challenges in drug safety and quality control. The initiative is also aligned with broader African Union goals of strengthening health systems and ensuring access to safe and effective medicines across the continent.

Moreover, the collaboration is expected to enhance consumer confidence in locally available pharmaceuticals and support the development of a more competitive pharmaceutical industry in Mauritania. By leveraging ALGERAC’s expertise, LMCM is poised to become a regional reference in drug quality control.

Conclusion: A Step Forward for Pharmaceutical Excellence

The new partnership between the Mauritanian Drug Control Laboratory and the Algerian Accreditation Body represents a forward-looking approach to public health and regulatory cooperation. Through shared expertise, capacity building, and a commitment to international standards, this collaboration is set to strengthen the quality and safety of medicines in Mauritania and beyond. It is a promising example of how regional partnerships can drive progress in critical sectors such as healthcare and pharmaceutical regulation.